Iron Deficiency (Without Anemia) Clinical Trial
Official title:
Hydroponic Fortification and Dietary App Effect on Vitamin B12 and Iron (Fe) Status - The Harvest Study, A Randomised Double-blinded Study
Verified date | February 2023 |
Source | Quadram Institute Bioscience |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Veganism and vegetarianism have clear benefits where they have a lower risk of many health issues. However, they also have a higher risk of nutrients and vitamin deficiency such as iron and vitamin B12. Iron can be found in plant-based food but in varying quantities, whereas vitamin B12 is mainly found in red meat, thus vegans and vegetarians can only take this vitamin in supplements such as tablets. In this study, the investigators are testing two interventions, the consumption of recipes with a certain iron amount to increase iron levels, and the consumption of vitamin B12 biofortified plants to increase serum B12 levels in vegan and vegetarian participants.
Status | Enrolling by invitation |
Enrollment | 52 |
Est. completion date | September 1, 2025 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: 1. Women over 18 years with a regular menstruation cycle (>21 and <40 days). 2. Has followed a vegan or vegetarian diet that does not include the consumption of meat or fish for at least 1 year. 3. Willing to remain on their background diet for the duration of the study. 4. Those who are on a routine regimen of iron and/or vitamin B12 supplements must maintain the same doses 3 month prior to the study and during the duration of the study. 5. Non-anaemic, haemoglobin (Hb) concentration =120 g/L. 6. SF >15 µg/L and <40 µg/L [WHO uses the following cut-offs for context: below 15 µg/L indicates iron deficiency, 16-40 µg/L indicates borderline deficiency, and 41 - 150 µg/L is normal]. 7. Body Mass Index (BMI) between 18.5 - 40 kg/m2. 8. Live within 40 miles of the Norwich Research Park. 9. Willing to consume plants grown in the hydroponic unit (e.g., spinach, rocket, mizuna) if they agreed to have a unit. 10. Access to a smartphone or online platform a well as access to the internet. Exclusion Criteria: 1. Those who have known allergies to the hydroponically grown salad greens (spinach, rocket, mizuna). 2. Flexitarian (consumes meat intermittently) vegetarian. 3. Those with menstruation cycle time periods of <21 or >40-days 4. BMI at screening visit < 18.5 kg/m2 (underweight) and > 40 kg/m2 (severely obese). 5. Those diagnosed with or undergoing treatment for anaemia. 6. Currently pregnant, lactating or trying to conceive. 7. High alcohol consumption, consuming more than 2 drinks per day, can elevate the risk for iron overload. 8. Current smoker or has only ceased in the last 6 months. 9. Diagnosed medical conditions that may impact the study outcomes will be considered on an individual basis. 10. Those with an eating disorders, which may impact the study outcome. 11. On, or about to start, a diet programme such as the 5:2 programme (5:2 programme is where an individual would eat normally for five days a week, and fast for two days a week by reducing calorie consumption). 12. Unable to give written or verbal informed consent. 13. Individuals who cannot understand the written instructions/questionnaires. 14. Unwilling to give GP contact details. 15. Participating in another dietary intervention study or has given blood in another research study during the last 3 months. 16. Any person related to or living with any member of the study team. 17. Those who are part of the Line Manager/supervisory structure of the Chief Investigator. 18. Those who have been asked to self-isolate or have been diagnosed with COVID-19 in the last 14 days. However, participants can be rescreened 7 days after the isolation period. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Quadram Institute Bioscience | Norwich |
Lead Sponsor | Collaborator |
---|---|
Quadram Institute Bioscience | Norfolk and Norwich University Hospitals NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in serum ferritin after the dietary app intervention | Comparison of serum ferritin at baseline and after the intervention | Week: 0, 6/7 and 17 | |
Primary | Change of serum B12 after the hydroponic unit intervention | Comparison of serum B12 at baseline and after the intervention | Week: 6/7 and 17 | |
Secondary | Change in high sensitivity C-reactive protein (hsCRP) with dietary app (high or standard iron) recipe intervention | comparison of hsCRP at baseline and after dietary app intervention | Week: 0 to 6/7, 6/7 to 17, and 0 to 17 | |
Secondary | Change in full blood count (FBC) with dietary app (high or standard iron) recipe intervention | comparison of FBC in venous blood sample at baseline and after dietary app intervention | Week: 0 to 6/7, 6/7 to 17, and 0 to 17 | |
Secondary | Change in soluble transferrin receptor (sTfR) with dietary app (high or standard iron) recipe intervention | comparison of sTfR in venous blood sample at baseline and after dietary app intervention | Week: 0 to 6/7, 6/7 to 17, and 0 to 17 | |
Secondary | Change in alpha 1 acid glycoprotein (AGP) with dietary app (high or standard iron) recipe intervention | comparison of AGP in venous blood sample at baseline and after dietary app intervention | Week: 0 and 17 | |
Secondary | Change in holo-transcobalamin (Holo-TC) after the hydroponic unit (biofortification) intervention | Measurement of holo-TC in venous blood sample at baseline and after the hydroponic unit intervention | Week: 0 and 17 | |
Secondary | Change in methylmalonic acid (MMA) after the hydroponic unit (biofortification) intervention | Measurement of MMA in venous blood sample at baseline and after the hydroponic unit intervention | Week: 0 and 17 | |
Secondary | Change in total plasma homocysteine (tHcy) after the hydroponic unit (biofortification) intervention | Measurement of tHcy in venous blood sample at baseline and after the hydroponic unit intervention | Week: 0 and 17 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05869422 -
Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women
|
N/A | |
Completed |
NCT04216030 -
IP Peru, Bioavailability of Iron From Potatoes
|
N/A | |
Not yet recruiting |
NCT06264687 -
Hepcidin After Intravenous Iron Treatment
|
||
Completed |
NCT04735848 -
Plasma Hepcidin Response to Differently Dosed Iron Supplements
|
N/A | |
Completed |
NCT04465851 -
Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs
|
N/A | |
Completed |
NCT04636060 -
Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women
|
N/A | |
Completed |
NCT05467423 -
Effect of Low-dose Versus Standard-dose Iron Supplementation on the Gut Microbiome
|
N/A | |
Completed |
NCT05257343 -
Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels
|
N/A | |
Completed |
NCT03670537 -
Iron Parameters in Non-anemic First Trimester Gravidas
|
||
Recruiting |
NCT02949765 -
Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease
|
N/A | |
Completed |
NCT03228173 -
Iron Deficiency in Female State Fair Attendees
|
N/A | |
Completed |
NCT01383798 -
How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers?
|
N/A | |
Active, not recruiting |
NCT05500014 -
Effect of Altitude on Iron Absorption in Iron Depleted Women
|
N/A | |
Completed |
NCT06021171 -
Improving the Iron Status of Athletes With Pre-, Pro- and Synbiotics
|
N/A | |
Active, not recruiting |
NCT04228627 -
Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial
|
Phase 4 | |
Completed |
NCT04363905 -
Supplemental Iron Improves Submaximal Exercise Performance in Non-anemic Iron Depleted Women
|
N/A |